Abstract:Abstract Background: Multiple clinical genome-wide analysis identified that chromosome 16p13.11 is a hotspot associated with neuropsychiatric disorders such as autism, schizophrenia and epilepsy. Nodal modulator 1 (NOMO1), located on human chromosome 16p13.11, was considered as a candidate gene with neuropsychiatric disorders. However, it is unknown whether the nomo1 deficiency causes neurological abnormalities, and the molecular mechanisms and pathogenesis of the NOMO1 gene remain unclear. To study the effects of nomo1 deficiency on brain development and neuropsychiatric system, a nomo1 knockout zebrafish model was established.Methods: We developed a viable vertebrate model of nomo1 loss-of-function using CRISPR/Cas9 technology and characterized nomo1 mutant zebrafish. Phenotypic and functional studies of developing nomo1 mutant zebrafish, including morphological measurements, behavioral assays, and functional mechanistic analyses, were performed.Results: Morphological differences in the phenotype of nomo1-/- zebrafish gradually became less noticeable during development, however, the enlarged interstitial spaces in midbrain and hindbrain were detected in nomo1 mutant zebrafish. Meanwhile, the nomo1 deficiency caused the change of expression levels in neurotransmitters of γ-aminobutyrate, glutamate and serotonin. Interestingly, the nomo1 loss-of-function zebrafish model exhibited social defects and repetitive behaviors in juvenile, which represented autism-like behaviors. The transcriptome analysis showed different gene expression patterns in mutant zebrafish at the genetic level. Further results revealed that the neuroactive drug PTZ recovered the decreased locomotor phenotype in larval mutant zebrafish.Conclusions: In this study, we established a nomo1 vertebrate animal model using CRISPR/Cas9 gene editing approach. The loss-of-function of nomo1 displayed autism-like behaviors and altered levels of the γ-aminobutyrate, glutamate and serotonin in zebrafish, which provide evidence that nomo1 as a candidate gene for autism. The versatility of zebrafish model is contributed to studying NOMO1-related disorders and conducting drug screening in future.Limitations: Further studies are needed to determine whether an intervention with a neuroactive drug in nomo1-/- zebrafish to alter the behavioral phenotype is applicable to the behavior of human patients.

The Risk Genes for Neuropsychiatric Disorders negr1 and opcml Are Expressed throughout Zebrafish Brain Development

Impairments of cerebellar structure and function in a zebrafish KO of neuropsychiatric risk gene znf536

Heterogeneity and molecular programming of progenitors for motor neurons and oligodendrocytes

Zebrafish Models of Neurodevelopmental Disorders: Past, Present, and Future

Expression of Myelin Transcription Factor 1 and Lamin B Receptor Mediate Neural Progenitor Fate Transition in the Zebrafish Spinal Cord Pmn Domain

Diencephalic and Neuropeptidergic Dysfunction in Zebrafish with Autism Risk Mutations

Morphological, behavioral and molecular studies on CRISPR/Cas9-mediated knockout of the NOMO1 gene in zebrafish

Loss-of-function of the NOMO1 Gene Causes Neuropsychiatric Disorder-related Phenotypes

Integrative mRNA and miRNA Expression Profiles from Developing Zebrafish Head Highlight Brain-Preference Genes and Regulatory Networks

Zmiz1 is a novel regulator of brain development associated with autism and intellectual disability

Alteration of the neuronal and glial cell profiles in Neu1-deficient zebrafish

Loss of Zmiz1 in mice leads to impaired cortical development and autistic-like behaviors

Nervous system development related gene expression regulation in the zebrafish embryo after exposure to valproic acid and retinoic acid: A genome wide approach

Neurogranin-like immunoreactivity in the zebrafish brain during development

Shedding a Light on Dark Genes: A Comparative Expression Study of PRR12 Orthologues during Zebrafish Development

Using zebrafish to assess the impact of drugs on neural development and function

Alternative Promoter Use Governs the Expression of IgLON Cell Adhesion Molecules in Histogenetic Fields of the Embryonic Mouse Brain

Disrupted development of sensory systems and the cerebellum in a zebrafish mutant

Neuromuscular Disorders in Zebrafish: State of the Art and Future Perspectives

Nomo1 Deficiency Causes Autism-Like Behavior in Zebrafish.

Involvement of nr2f genes in brain regionalization and eye development during early zebrafish development